Gilead Sciences Inc - Company Profile
Powered by
All the data and insights you need on Gilead Sciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Gilead Sciences Inc Strategy Report
- Understand Gilead Sciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreView up-to-date information on Gilead Sciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
15 Aug 2022 | Gilead Sciences to Receive Rights of Trodelvy from Everest Medicines | Licensing Agreement |
Immunomedics Inc
|
Everest Medicines Ltd
|
04 Aug 2022 | Gilead Sciences Acquires MiroBio | Acquisition |
Gilead Sciences Inc
|
MiroBio Ltd
|
27 Jul 2022 | AlloVir to Raise USD126.6 Million in Registered Direct Offering | Private Equity |
GMT Capital Corp
Invus Group LLC
Kite Pharma Inc
F2 Ventures Limited (Inactive)
EcoR1 Capital LLC
ElevateBio LLC
Redmile Group LLC
|
AlloVir Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer